Although the mechanism responsible for this increase in hepatic lipogenesis is unclear, selective insulin resistance has long been observed in fatty liver, which is manifested by insulin resistance to the suppression of hepatic glucose production but preserves insulin sensitivity in the SREBP1c pathway that stimulates fatty acid synthesis. The gene discussed is INS; the disease is Insulin resistance.